South China Morning Post
AsiaPac · 3 hrs ago
✦ 72◉ Centre
Hong Kong biotech firm uses AI to produce nano-rockets that deliver life-saving drugs
72Accuracy
0Ratings
0Comments
AI Analysis
Accuracy 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ⚠ Misleading headline
A Hong Kong biotech start-up, METiS TechBio, has launched using AI to accelerate drug development from years to 18 months, with the founder comparing the company's approach to SpaceX's innovation model.
Hong Kong biotech firm uses AI to produce nano-rockets that deliver life-saving drugs
Artificial intelligence has shortened drug development from years to just 18 months, the founder of METiS TechBio said, as the AI-driven drug design start-up made its Hong Kong debut on Wednesday amid strong investor appetite for AI-related stocks in the city.
“We see ourselves like a SpaceX-style company,” Lai Tsai-Ta, co-founder and CEO of METiS TechBio, who obtained a PhD from the Massachusetts Institute of Technology in the US, said.
“We use AI algorithms to design a large number of...
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!